CTOs on the Move

Genomics Institute of the Novartis Research Foun

www.gnf.org

 
Genomics Institute of the Novartis Research Foundation (GNF) is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.gnf.org
  • 10675 John J Hopkins Dr
    San Diego, CA USA 92121
  • Phone: 858.812.1500

Executives

Name Title Contact Details

Similar Companies

Optum

Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. Optum comprises three companies â€" OptumHealth, OptumInsight and OptumRx â€" representing more than 35,000 employees worldwide who collaborate to deliver integrated, intelligent solutions that work to modernize the health system and improve overall population health.

East Texas Council on Alcoholism

East Texas Council on Alcoholism is a Longview, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Holly Hill Manor

Holly Hill Manor is a Towson, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Virginia Hospital

Virginia Hospital is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Sarepta

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases.